Authors


Ray Pary, MD, Paul R. Matuschka, PharmD, Susan Lewis, ARNP, PhD

Latest:

Recognizing Posttraumatic Stress Disorder and Its Comorbidities

Posttraumatic stress disorder is the fourth most common psychiatric condition, affecting about 1 in 10 people at some point during their lifetime. The principal cause is exposure to an extremely traumatic event. The individual's unique biologic or psychosocial character and previous exposure, along with the personal significance of the trauma, shape the intensity of the response. Early recognition of trauma symptoms and signs and prompt intervention are important in the prevention of acute stress disorder and the subsequent development of posttraumatic stress disorder. Obtaining a trauma history during a routine medical examination can lead to the diagnosis and help initiate treatment. In addition to being distressing, symptoms also diminish quality of life, impair psychosocial adjustment, and worsen overall health.


Albert Schömig, MD2

Latest:

Noninvasive assessment of coronary artery bypass grafts with 64-slice computed tomographic angiography

We evaluated the accuracy of the 64-slice computed tomography (CT) angiography scanner in subjects who were scheduled to undergo invasive angiography for possible stenosis in coronary artery bypass grafts. Results showed that the improved resolution of CT scanners with 64-slice technology allowed for a precise delineation of bypass graft occlusion or stenosis. It permitted an accurate noninvasive assessment of bypass grafts, even in subgroups of subjects with suboptimal scan conditions, such as those with arrhythmias or higher heart rates.



Jeffrey Ceresnak, MD

Latest:

Uncontrolled asthma and Cushing's syndrome: Where does anti-IgE fit in?

Steroid treatments are a first-line therapy for asthma but can have considerable side effects, such as Cushing's syndrome. Patients who develop such complications or become intolerant to steroid therapy may be candidates for anti-IgE treatment.





Paul Vermeersch, MD

Latest:

Late mortality with sirolimus-eluting stents in diseased saphenous vein grafts

In a secondary post-hoc analysis of the Reduction of Restenosis in Saphenous Vein Grafts with Cypher (RRISC) trial, we compared the long-term safety of sirolimus-eluting stents (SES) with bare-metal stents (BMS) in diseased saphenous vein grafts


Collegium Pharmaceutical, Inc.

Latest:

OPIOIDIQ: Educational tools for proper opioid use

Brought to you by Collegium Pharmaceutical, Inc.: OpioidIQ offers downloadable tools to help you identify unintentional opioid misuse, enhance patient communication, and optimize treatment management.


Surender Malhotra, MD

Latest:

Congenital absence of right coronary artery without any other associated anomalies

Anomalous coronary arteries are rare congenital cardiac defects with varying symptomatology and controversial clinical significance. These should be considered as a differential diagnosis, particularly when coronary schemia occurs in a child or young adult.


Justin Barad, MD

Latest:

Opinion: Disrupting Healthcare Is All in the Delivery

How history shows us that changing dogma in healthcare practice requires a multi-faceted approach.




Lauren Sobel, DO, MPH

Latest:

Providing Obstetric Care for Women with a History of Sexual Trauma

We asked women with a history of sexual trauma about their pregnancy and childbirth experiences and used their experiences and insight to inform practice recommendations.



Byron J. Hoogwerf, MD

Latest:

Blockade of the RAA system in diabetic patients: ACE inhibition, ARBs, and the potential role of direct renin inhibition

Modulation of the renin-angiotensin-aldosterone (RAA) system using angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) has been shown to have beneficial effects on blood pressure, diabetic nephropathy, coronary heart disease, and heart failure.




Sucheta Gosavi, MD

Latest:

Glycemic Control and Excess Mortality in Patients with Type 1 Diabetes Mellitus

Mortality in patients with type 1 diabetes mellitus (T1DM) is higher than in the general population, and whether mortality improves or alters with glycemic control is unknown.


Paul van den Heuvel, MD

Latest:

Late mortality with sirolimus-eluting stents in diseased saphenous vein grafts

In a secondary post-hoc analysis of the Reduction of Restenosis in Saphenous Vein Grafts with Cypher (RRISC) trial, we compared the long-term safety of sirolimus-eluting stents (SES) with bare-metal stents (BMS) in diseased saphenous vein grafts




Thomas Stamos, MD2: From the Departments of 1Internal Medicine

Latest:

Community-acquired MRSA pericarditis

Only 2 cases of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) pericarditis have been reported in the English literature. Over the last 15 years, CA-MRSA has emerged as an increasingly common pathogen that is genetically and epidemiologically different from hospital-acquired MRSA (HA-MRSA).





Bryan Hess, MD, Rebecca Maury, MD

Latest:

Human Papillomavirus Infection: Current Approach to Prevention

Preventing HPV infection is tantamount to cervical cancer eradication. New vaccines offer protection against many HPV serotypes, but even vaccinated women should be screened for cervical cancer.


Stephen C. Vlay, MD, is professor of medicine, Cardiology Division, State University of New York Health Sciences Center, Stony Brook, New York.

Latest:

Evaluating the lifetime risk of atrial fibrillation

Data from the Framingham study provide yet more valuable prognostic information, this time related to the most common cardiac arrhythmia, atrial fibrillation.



© 2024 MJH Life Sciences

All rights reserved.